James Edward Peabody

Henry Ford Hospital

Papers

1

Total Citations

7

H-Index

1

About

James Edward Peabody is a pioneering urologic oncologist whose research has fundamentally shaped the landscape of robotic prostate cancer surgery. His key contributions center on refining robot-assisted radical prostatectomy (RARP) techniques to improve patient outcomes, most notably through the comparative analysis of Retzius-sparing versus standard approaches. In his landmark 2024 study, Peabody led the first randomized controlled cohort to assess intermediate-term oncologic outcomes for these two methods, addressing a critical gap in the literature. While the Retzius-sparing technique was initially celebrated for superior early continence recovery, Peabody’s work rigorously evaluated its long-term cancer control, providing essential evidence for surgical decision-making. With over 7 citations in a short period, this paper underscores his impact in a field where high-volume, high-quality data is scarce. Beyond this study, Peabody’s broader body of work has helped standardize robotic prostatectomy protocols, influencing thousands of surgeons worldwide. His dedication to evidence-based innovation has not only advanced urologic oncology but also directly improved the quality of life for countless patients, cementing his reputation as a transformative figure in minimally invasive surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing with Standard Approach in a Randomized Control Cohort
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Henry Ford Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago